您的位置：
首页
>
农业专利
>
详情页
IMIDAZOPYRIDAZINES SUBSTITUEES ET LEUR UTILISATION
专利权人:
BAYER INTELLECTUAL PROPERTY GMBH;BAYER PHARMA AKTIENGESELLSCHAFT
发明人:
FOLLMANN, MARKUS,STASCH, JOHANNES-PETER,REDLICH, GORDEN,STRAUB, ALEXANDER,ACKERSTAFF, JENS,GRIEBENOW, NILS,KNORR, ANDREAS,WUNDER, FRANK,LI, VOLKHART MIN-JIAN
申请号：
CA2834903
公开号：
CA2834903A1
申请日:
2012.05.02
申请国别(地区):
CA
年份:
2012
代理人:
摘要：
The invention relates to novel substituted imidazopyridazines, to a method for the production thereof, to the individual or combined use thereof for the treatment and/or prophylaxis of diseases, and to the use thereof for producing medicaments for the treatment and/or prophylaxis of diseases, especially for the treatment and/or prophylaxis of cardiovascular diseases.
来源网站：
中国工程科技知识中心
来源网址：
http://www.ckcest.cn/home/
相关专利
IMIDAZOPYRIDAZINES SUBSTITUEES ET IMIDAZOPYRIDAZINES, ET LEUR UTILISATION
מערכת ושיטה לניבוי השפעה של טיפול רפואי
Cardiovascular disease treatment methods and prevention of the effectiveness of exercise therapy
composition, method, risk reduction method, prevention or treatment of an individual having an autoimmune disease or disorder, method of inducing degradation of a target protein in a cell, method for reducing risk, preventing or treating a disease state or disorder in a patient wherein the unregulated protein activity is responsible for said disease or condition, method for reducing the risk, preventing or treating cancer in an individual, and method of treating a genetic disease or disorder in an individual
METHOD FOR IDENTIFYING A RISK OF CARDIOVASCULAR DISEASE BY ANALYSING ORAL MICROBIOTA
